These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1172464)

  • 1. [Severe side-effects of treatment with D-penicillamine (author's transl)].
    Hennemann HH; Hubertus H; Stocker WG
    Dtsch Med Wochenschr; 1975 Aug; 100(32):1634-8. PubMed ID: 1172464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evans' syndrome caused by D-penicillamine in rheumatoid arthritis. Value of the corticoids-danazol combination].
    Masson C; Brégeon C; Ifrah N; Berton V; Housseau F; Rénier JC
    Rev Rhum Mal Osteoartic; 1991; 58(7):519-22. PubMed ID: 1925397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic thrombocytopenic purpura during penicillamine therapy in rheumatoid arthritis.
    Trice JM; Pinals RS; Plitman GI
    Arch Intern Med; 1983 Jul; 143(7):1487-8. PubMed ID: 6683487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case report of rheumatoid arthritis which showed acute renal failure, nephrotic syndrome and drug-related lupus-like syndrome caused by D-penicillamine].
    Suda M; Yoshikawa Y; Suzuki T; Dohi Y; Shibata T
    Nihon Jinzo Gakkai Shi; 1990 Nov; 32(11):1235-41. PubMed ID: 2082056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Penicillamine-induced myasthenia in chronic rheumatoid arthritis (author's transl)].
    Seitz D; Hopf HC; Janzen RW; Meyer W
    Dtsch Med Wochenschr; 1976 Jul; 101(31):1153-8. PubMed ID: 976101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study.
    Bacon PA; Tribe CR; Mackenzie JC; Verrier-Jones J; Cumming RH; Amer B
    Q J Med; 1976 Oct; 45(180):661-84. PubMed ID: 1005658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longterm followup of treatment with D-penicillamine for rheumatoid arthritis: effectivity and toxicity in relation to HLA antigens.
    Moens HJ; Ament BJ; Feltkamp BW; van der Korst JK
    J Rheumatol; 1987 Dec; 14(6):1115-9. PubMed ID: 3437418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lupus biology: incidence and development in 84 rheumatoid polyarthritis patients treated with D-penicillamine].
    Clerc D; Sallière D; Segond P; Bisson M; Massias P
    Ann Med Interne (Paris); 1984; 135(6):420-6. PubMed ID: 6334465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [D-penicillamine in the treatment of rheumatoid polyarthritis. 104 cases with a 5-year follow-up].
    Valat JP; Fouquet B; Eveleigh MC; Chantreuil C; Lalot F
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):7-12. PubMed ID: 3704516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and prognostic significance of antinuclear factors during D-penicillamine treatment (author's transl)].
    Helmke K; Velcovsky HG; Federlin K
    Dtsch Med Wochenschr; 1975 Oct; 100(43):2198-203. PubMed ID: 1080704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nephrotic syndrome after treatment with penicillamine in Wilson's disease].
    Hampel R; Meng W; Kallwellis G
    Z Gesamte Inn Med; 1976 Jul; 31(13):507-11. PubMed ID: 960872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ocular myasthenia caused by D-penicillamine (author's transl)].
    Schmidt D; Kommerell G
    Klin Monbl Augenheilkd; 1976 Mar; 168(3):409-13. PubMed ID: 966573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The side effects of penicillamine therapy in rheumatoid arthritis.
    Huskisson EC
    J Rheumatol Suppl; 1981; 7():146-8. PubMed ID: 6939876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long term treatment of rheumatoid arthritis. Experiences with D-penicillamine in comparison with gold and immunosuppressive drugs (author's transl)].
    Warnatz H; Scheiffarth F; Gutmann W
    Med Klin; 1975 Sep; 70(38):1509-15. PubMed ID: 810648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Minimal changes nephrotic syndrome associated to penicillamine treatment].
    Basterrechea MA; de Arriba G; García-Martín F; Sánchez-Heras M; Giménez-Vega E; Sánchez J
    Nefrologia; 2004; 24(2):183-7. PubMed ID: 15219094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Penicillamine: its use in rheumatoid arthritis].
    Colombo B; Gerloni V
    Recenti Prog Med; 1979 Feb; 66(2):136-87. PubMed ID: 155862
    [No Abstract]   [Full Text] [Related]  

  • 17. [Administration of D-penicillamine instead of penicillin with fatal results: allergy of the delayed type with protracted shock as fatal complication of treatment with D-penicillamine for rheumatoid arthritis in a child (author's transl)].
    Erkrath KD; Adebahr G; Klöppel A
    Dtsch Med Wochenschr; 1980 Aug; 105(32):1121-3. PubMed ID: 7428632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The basal therapy of rheumatoid arthritis with d-penicillamine (author's transl)].
    Waskönig FW; Meyer W
    Munch Med Wochenschr; 1973 Nov; 115(45):2047-50. PubMed ID: 4801138
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acetylcholine receptor antibody in D-penicillamine therapy].
    Kolarz G; Maida EM
    Z Rheumatol; 1986; 45(3):118-21. PubMed ID: 3751350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine.
    Stockman A; Zilko PJ; Major GA; Tait BD; Property DN; Mathews JD; Hannah MC; McCluskey J; Muirden KD
    J Rheumatol; 1986 Apr; 13(2):269-73. PubMed ID: 3459889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.